Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment
https://doi.org/10.18087/cardio.2020.9.n1074
Abstract
This review focuses on the issue of atrial fibrillation (AF) following coronary bypass surgery in patients with ischemic heart disease. Risk factors of this complication are discussed in detail. The authors addressed the effect of diabetes mellitus on development of postoperative AF. Data on current methods for prevention and treatment of AF are provided.
Keywords
Supporting agencies: no conflict of interest
About the Authors
E. S. Petrakova
Central Clinical Hospital with Out-patient Clinic of the Department of Affairs of the President of the Russian Federation, Moscow
Russian Federation
Russian Federation
cardiologist, cardiac surgery department
N. M. Savina
Central State Medical Academy of Department of Presidential Affairs, Moscow
Russian Federation
Russian Federation
MD, professor
A. V. Molochkov
Central Clinical Hospital with Out-patient Clinic of the Department of Affairs of the President of the Russian Federation, Moscow
Russian Federation
Russian Federation
MD
References
1. Federal State Statistics Service. Health in Russia. 2019. Statistical book. -M.: Rosstat;2019. - 170 p. https://www.gks.ru/storage/mediabank/Zdravoohran-2019.pdf]. ISBN 978-5-89476-470-2
2. Fisenko V.S., Roginko N.I., Korochkin A.V. Achievement of the key performance targets for the reduction of mortality from diseases of the circulatory system in the subjects of the Russian Federation (as a result of monitoring and oversight by Roszdravnadzor). Bulletin of Roszdravnadzor. 2015;5:26–32.
3. Akchurin R.S., Shiryaev A.A., Vlasova E.E., Vasiliev V.P., Galyautdinov D.M. Surgical treatment of coronary heart disease. Russian Medical Journal. 2014;22(30):2152–7.
4. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. Heart Disease and Stroke Statistics–2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–360. DOI: 10.1161/CIR.0000000000000350
5. Favaloro RG. Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion. The Annals of Thoracic Surgery. 1968;5(4):334–9. DOI: 10.1016/S0003-4975(10)66351-5
6. Bokeria L.A., Avaliani V.M., Merzlyakov V.Yu. Coronary artery bypass grafting on a working heart. -M.: NTSSH im. A.N. Bakuleva RAMS;2008. - 490 p. ISBN 978-5-7982-0227-0
7. Osnabrugge RL, Kappetein AP, Head SJ, Kolh P. Doing better in more complex patients: leading the way for QUIP. European Journal of Cardio-Thoracic Surgery. 2016;49(2):397–8. DOI: 10.1093/ejcts/ezv262
8. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394
9. Weedle RC, Costa MD, Veerasingam D, Soo AWS. The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. Annals of Translational Medicine. 2019;7(23):778– 778. DOI: 10.21037/atm.2019.11.17
10. Zafiraki V.K., Skaletsky K.V., Stavenchuk T.V., Kosmacheva E.D. Perioperative complications of coronary artery bypass grafting with a combination of stable angina pectoris and chronic obstructive pulmonary disease. Kuban Scientific Medical Bulletin. 2014;3(145):49–53.
11. Thorén E, Hellgren L, Ståhle E. High incidence of atrial fibrillation after coronary surgery. Interactive CardioVascular and Thoracic Surgery. 2016;22(2):176–80. DOI: 10.1093/icvts/ivv326
12. Filardo G, Damiano RJ, Ailawadi G, Thourani VH, Pollock BD, Sass DM et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 2018;104(12):985–92. DOI: 10.1136/heartjnl-2017-312150
13. Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. European Journal of Cardio-Thoracic Surgery. 2017;52(4):665–72. DOI: 10.1093/ejcts/ezx039
14. Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. New England Journal of Medicine. 2016;374(20):1911–21. DOI: 10.1056/NEJMoa1602002
15. Bokeria L.A., Golukhova E.Z., Alshibaya M.D., Kakuchaya T.T. Prediction of the development of atrial fibrillation after coronary artery bypass grafting. Annals of arrhythmology. 2004;1(1):77– 86.
16. Melby SJ, George JF, Picone DJ, Wallace JP, Davies JE, George DJ et al. A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. The Journal of Thoracic and Cardiovascular Surgery. 2015;149(3):886–92. DOI: 10.1016/j.jtcvs.2014.11.032
17. Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery. Journal of the American College of Cardiology. 2008;51(8):793–801. DOI: 10.1016/j.jacc.2007.10.043
18. Auer J, Weber T, Berent R, Ng C-K, Lamm G, Eber B. Risk Factors of Postoperative Atrial Fibrillation After Cardiac Surgery. Journal of Cardiac Surgery. 2005;20(5):425–31. DOI: 10.1111/j.1540-8191.2005.2004123.x
19. Bokeria L.A., Bokeria O.L., Gafurov F.S. Current State of the Problem in Prevention of Atrial Fibrillation in the Early Postoperative Period after Coronary Artery Bypass Surgery. Surgery News. 2018;26(5):605–15. DOI: 10.18484/2305-0047.2018.5.605
20. Hernández-Leiva E, Alvarado P, Dennis RJ. Postoperative Atrial Fibrillation: Evaluation of its Economic Impact on the Costs of Cardiac Surgery. Brazilian Journal of Cardiovascular Surgery. 2019;34(2):179–86. DOI: 10.21470/1678-9741-2018-0218
21. Megens MR, Churilov L, Thijs V. New‐Onset Atrial Fibrillation After Coronary Artery Bypass Graft and Long‐Term Risk of Stroke: A Meta‐Analysis. Journal of the American Heart Association. 2017;6(12):e007558. DOI: 10.1161/JAHA.117.007558
22. Burrage PS, Low YH, Campbell NG, O’Brien B. New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery. Current Anesthesiology Reports. 2019;9(2):174–93. DOI: 10.1007/s40140-019-00321-4
23. Lomivorotov V.V., Efremov S.M., Pokushаlov E.А., Boboshko V.А. Atrial fibrillation after cardiac surgery: pathophysiology and methods of prevention. Bulletin of Anesthesiology and Resuscitation. 2017;14(1):58–66. DOI: 10.21292/2078-5658-2017-14-1-58-66
24. Folla C de O, Melo CC de S, Silva R de CG e, Universidade de São Paulo, Brazil, Universidade de São Paulo, Brazil. Predictive factors of atrial fibrillation after coronary artery bypass grafting. Einstein (São Paulo). 2016;14(4):480–5. DOI: 10.1590/s1679-45082016ao3673
25. Melikulov A.Kh., Maglakelidze D.A. Possible mechanisms and strategies for preventing atrial fibrillation after open heart surgery. Annals of arrhythmology. 2012;9(1):13–9.
26. Mathew JP. A Multicenter Risk Index for Atrial Fibrillation After Cardiac Surgery. JAMA. 2004;291(14):1720–9. DOI: 10.1001/jama.291.14.1720
27. Ommen SR, Odell JA, Stanton MS. Atrial Arrhythmias after Cardiothoracic Surgery. New England Journal of Medicine. 1997;336(20):1429–34. DOI: 10.1056/NEJM199705153362006
28. Cerit L, Kemal H, Gulsen K, Ozcem B, Cerit Z, Duygu H. Relationship between Vitamin D and the development of atrial fibrillation after on-pump coronary artery bypass graft surgery. Cardiovascular Journal of Africa. 2017;28(2):104–7. DOI: 10.5830/CVJA-2016-064
29. Ferreira AF, Saraiva FA, Cerqueira RJ, Moreira R, Amorim MJ, Pinho P et al. P1243Postoperative atrial fibrillation after coronary artery bypass grafting surgery. European Heart Journal. 2018;39(Suppl 1):245. DOI: 10.1093/eurheartj/ehy565.P1243
30. Goette A, Juenemann G, Peters B, Klein H, Roessner A, Huth C et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovascular Research. 2002;54(2):390–6. DOI: 10.1016/S0008-6363(02)00251-1
31. Jannati M. Atrial Fibrillation Post Coronary Artery Graft Surgery: A Review Of Literature. International Journal of General Medicine. 2019;12:415–20. DOI: 10.2147/IJGM.S227761
32. Avdic S, Osmanovic E, Kadric N, Mujanovic E, Ibisevic M, Avdici and. Time of Occurrence and Duration of Atrial Fibrillation Following Coronary Artery Bypass Grafting. Medical Archives. 2016;70(2):97–100. DOI: 10.5455/medarh.2016.70.97-100
33. Wang W-H, Hsiao S-H, Lin K-L, Wu C-J, Kang P-L, Chiou K-R. Left Atrial Expansion Index for Predicting Atrial Fibrillation and In-Hospital Mortality After Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery. 2012;93(3):796–803. DOI: 10.1016/j.athoracsur.2011.11.007
34. Zhou A-G, Wang X-X, Pan D-B, Chen A, Zhang X, Deng H. Preoperative Antihypertensive Medication in Relation to Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis. BioMed Research International. 2017;2017:1– 12. DOI: 10.1155/2017/1203538
35. Peretto G, Durante A, Limite LR, Cianflone D. Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management. Cardiology Research and Practice. 2014;2014:615987. DOI: 10.1155/2014/615987
36. Bayrakova Yu.V., Ivanov S.V., Kazachek Ya.V., Bazdyrev E.D., Malyshenko E.S., Кurguzova E.M. et al. Risk factors for inhospital supraventricular rhythm disturbances after coronary bypass surgery. Siberian Medical Journal (Irkutsk). 2011;104(5):44–7.
37. Dublin S. Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index. Archives of Internal Medicine. 2006;166(21):2322. DOI: 10.1001/archinte.166.21.2322
38. Echahidi N, Mohty D, Pibarot P, Despres J-P, O’Hara G, Champagne J et al. Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Circulation. 2007;116(11 Suppl):I213-219. DOI: 10.1161/CIRCULATIONAHA.106.681304
39. Sim MA, Liu W, Chew STH, Ti LK. Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay. PLOS ONE. 2018;13(6):e0198533. DOI: 10.1371/journal.pone.0198533
40. Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 2011;41(1):102–7. DOI: 10.1016/j.ejcts.2011.04.011
41. Kolesnikov V.N., Boeva O.I., Ivanenko A.S., Yagoda A.V. Predicting new-onset atrial fibrillation after coronary artery bypass surgery: a prospective comparative study. Medical news of the North Caucasus. 2014;9(4):320–5. DOI: 10.14300/mnnc.2014.09090
42. Saskin H, Duzyol Ç, Aksoy R, Ozcan KS, Güngö B, İdiz M. Do preoperative C-reactive protein and mean platelet volume levels predict development of postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting? Advances in Interventional Cardiology. 2016;12(2):156–63. DOI: 10.5114/aic.2016.59366
43. Demir M, Uyan U, Melek M. The Effects of Vitamin D Deficiency on Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis. 2014;20(1):98–103. DOI: 10.1177/1076029612453762
44. Zhang Z, Yang Y, Ng CY, Wang D, Wang J, Li G et al. Metaanalysis of Vitamin D Deficiency and Risk of Atrial Fibrillation: Vitamin D deficiency and risk of AF. Clinical Cardiology. 2016;39(9):537–43. DOI: 10.1002/clc.22563
45. Ozsin KK, Sanrı US, Toktaş F, Kahraman N, Yavuz Ş. Effect of Plasma Level of Vitamin D on Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Brazilian Journal of Cardiovascular Surgery. 2018;33(3):217–23. DOI: 10.21470/1678-9741-2017-0214
46. Puskas JD, Edwards FH, Pappas PA, O’Brien S, Peterson ED, Kilgo P et al. Off-Pump Techniques Benefit Men and Women and Narrow the Disparity in Mortality After Coronary Bypass Grafting. The Annals of Thoracic Surgery. 2007;84(5):1447–56. DOI: 10.1016/j.athoracsur.2007.06.104
47. Williams JB, Peterson ED, Wojdyla D, Harskamp R, Southerland KW, Ferguson TB et al. Central venous pressure after coronary artery bypass surgery: Does it predict postoperative mortality or renal failure? Journal of Critical Care. 2014;29(6):1006–10. DOI: 10.1016/j.jcrc.2014.05.027
48. Costa MAC da, Lirani W, Wippich AC, Lopes L, Tolentino E de S, Zampar B et al. Comparison of Two Central Venous Pressure Control Strategies to Prevent Atrial Fibrillation After Coronary Artery Bypass Grafting. Arquivos Brasileiros de Cardiologia. 2017;108(4):297–303. DOI: 10.5935/abc.20170044
49. Bazylev V.V., Nemchenko E.V., Slastin Ya.S., Karnakhin V.A., Pavlov A.A. The relationship between the SYNTAX score and atrial fibrillation in the early postoperative period in patients after isolated coronary artery bypass grafting. CardioSomatics. 2018;8(1):5–9. DOI: 10.26442/2221-7185_2018.1.5-9
50. Todorov H, Janssen I, Honndorf S, Bause D, Gottschalk A, Baasner S et al. Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery – a retrospective data analysis. BMC Anesthesiology. 2017;17(1):163–73. DOI: 10.1186/s12871-017-0455-7
51. Yadava M, Hughey AB, Crawford TC. Postoperative Atrial Fibrillation: incidence, mechanisms, and clinical correlates. Heart Failure Clinics. 2016;12(2):299–308. DOI: 10.1016/j.hfc.2015.08.023
52. Kramer PA, Chacko BK, Ravi S, Johnson MS, Mitchell T, Barnes S et al. Hemoglobin-associated oxidative stress in the pericardial compartment of postoperative cardiac surgery patients. Laboratory Investigation. 2015;95(2):132–41. DOI: 10.1038/labinvest.2014.144
53. Anselmi A, Possati G, Gaudino M. Postoperative Inflammatory Reaction and Atrial Fibrillation: Simple Correlation or Causation? The Annals of Thoracic Surgery. 2009;88(1):326–33. DOI: 10.1016/j.athoracsur.2009.01.031
54. D’Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. The Annals of Thoracic Surgery. 2018;105(1):15–23. DOI: 10.1016/j.athoracsur.2017.10.035
55. Akchurin R.S., Vlasova E.E., Mershin K.V. Diabetus mellitus and surgical treatment of coronary heart disease. Annals of the Russian Academy of Medical Sciences. 2012;67(1):14–9.
56. World Health Organization. Global report on diabetes. –Geneva: WHO;2018. - 88 p. ISBN 978-92-4-456525-4
57. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2020;41(2):255–323. DOI: 10.1093/eurheartj/ehz486
58. Bundhun PK, Wu ZJ, Chen M-H. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovascular Diabetology. 2016;15(1):2. DOI: 10.1186/s12933-015-0323-z
59. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary Artery Bypass Graft Surgery vs Percutaneous Interventions in Coronary Revascularization: A Systematic Review. JAMA. 2013;310(19):2086–95. DOI: 10.1001/jama.2013.281718
60. Renner A, Zittermann A, Aboud A, Pühler T, Hakim-Meibodi K, Quester W et al. Coronary Revascularization in Diabetic Patients: Off-Pump Versus On-Pump Surgery. The Annals of Thoracic Surgery. 2013;96(2):528–34. DOI: 10.1016/j.athoracsur.2013.04.063
61. Raza S, Sabik JF, Masabni K, Ainkaran P, Lytle BW, Blackstone EH. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(4):1257-1266. e9. DOI: 10.1016/j.jtcvs.2014.06.058
62. Tatsuishi W, Adachi H, Murata M, Tomono J, Okonogi S, Okada S et al. Postoperative Hyperglycemia and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Circulation Journal. 2014;79(1):112–8. DOI: 10.1253/circj.CJ-14-0989
63. Sato H, Hosojima M, Ishikawa T, Aoki K, Okamoto T, Saito A et al. Glucose Variability Based on Continuous Glucose Monitoring Assessment Is Associated with Postoperative Complications after Cardiovascular Surgery. Annals of Thoracic and Cardiovascular Surgery. 2017;23(5):239–47. DOI: 10.5761/atcs.oa.17-00045
64. Bezdenezhnykh N.A., Sumin A.N., Barbarash O.L. Diabetes patient and myocardial revascularization from the evidence guided perspective: cardiologist opinion. Part 1. Russian Journal of Cardiology. 2017;22(4):105–13. DOI: 10.15829/1560-4071-2017- 4-105-113
65. Sumin A.N., Bezdenezhnykh N.A., Bezdenezhnykh A.V., Osokina A.V., Kuzmina A.A., Gruzdeva O.V. et al. Pre-surgery status and in-hospital complications of coronary bypass grafting in prediabetes and type 2 diabetes patients. Russian Journal of Cardiology. 2018;23(5):40–8. DOI: 10.15829/1560-4071-2018-5-40-48
66. Ujueta F, Weiss EN, Sedlis SP, Shah B. Glycemic Control in Coronary Revascularization. Current Treatment Options in Cardiovascular Medicine. 2016;18(2):12. DOI: 10.1007/s11936-015-0434-6
67. Gatti G, Dell’Angela L, Maschietto L, Luzzati R, Sinagra G, Pappalardo A. The Impact of Diabetes on Early Outcomes after Routine Bilateral Internal Thoracic Artery Grafting. Heart, Lung and Circulation. 2016;25(8):862–9. DOI: 10.1016/j.hlc.2016.02.009
68. Sumin A.N., Bezdenezhnykh N.A., Ivanov S.V., Barbarash O.L., Barbarash L.S. On the risk of postoperative complications of coronary bypass surgery in patients with type II diabetes. The Bulletin of Bakoulev Center Cardiovascular Diseases. 2012;13(5):59– 68.
69. Sumin A.N., Bezdenezhnykh N.A., Bezdenezhnykh A.V., Ivanov S.V., Barbarash O.L. Risk factors of major cardiovascular events in long-term period of coronary bypass in patients with ischemic heart disease and 2nd type diabetes mellitus. Russian Journal of Cardiology. 2015;20(6):30–7.
70. Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J et al. Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American Journal of Cardiology. 2014;114(8):1217–22. DOI: 10.1016/j.amjcard.2014.07.045
71. Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression. PLOS ONE. 2017;12(3):e0170955. DOI: 10.1371/journal.pone.0170955
72. Surer S, Seren M, Saydam O, Bulut A, Kiziltepe U. The Relationship between HbA1c and Atrial fibrillation After Off-pump Coronary Artery Bypass Surgery in Diabetic Patients. Pakistan Journal of Medical Sciences. 2016;32(1):59–64. DOI: 10.12669/pjms.321.8588
73. Subramaniam B, Lerner A, Novack V, Khabbaz K, Paryente-Wiesmann M, Hess P et al. Increased Glycemic Variability in Patients with Elevated Preoperative HbA1c Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery. Anesthesia & Analgesia. 2014;118(2):277–87. DOI: 10.1213/ANE.0000000000000100
74. Alawami M, Chatfield A, Ghashi R, Walker L. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. Journal of the Saudi Heart Association. 2018;30(1):40–6. DOI: 10.1016/j.jsha.2017.03.008
75. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. DOI: 10.1093/europace/euw295
76. Thein PM, White K, Banker K, Lunny C, Mirzaee S, Nasis A. Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis. Heart, Lung and Circulation. 2018;27(3):310–21. DOI: 10.1016/j.hlc.2017.08.026
77. Turagam MK, Downey FX, Kress DC, Sra J, Tajik AJ, Jahangir A. Pharmacological strategies for prevention of postoperative atrial fibrillation. Expert Review of Clinical Pharmacology. 2015;8(2):233–50. DOI: 10.1586/17512433.2015.1018182
78. Wang H-S, Wang Z-W, Yin Z-T. Carvedilol for Prevention of Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis. PLoS ONE. 2014;9(4):e94005. DOI: 10.1371/journal.pone.0094005
79. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. European Heart Journal. 2006;27(23):2846–57. DOI: 10.1093/eurheartj/ehl272
80. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery. New England Journal of Medicine. 2005;353(4):349–61. DOI: 10.1056/NEJMoa041895
81. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. The Lancet. 2008;371(9627):1839–47. DOI: 10.1016/S0140-6736(08)60601-7
82. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24):2215–45. DOI: 10.1161/CIR.0000000000000105
83. Kerin NZ, Jacob S. The Efficacy of Sotalol in Preventing Postoperative Atrial Fibrillation: A Meta-Analysis. The American Journal of Medicine. 2011;124(9):875.e1-875.e9. DOI: 10.1016/j.amjmed.2011.04.025
84. Somberg J, Molnar J. Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. Journal of Atrial Fibrillation. 2016;8(5):1359. DOI: 10.4022/jafib.1359
85. Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19(2):190– 225. DOI: 10.1093/europace/euw242
86. Balik M, Sander M, Trimmel H, Heinz G. Landiolol for managing post-operative atrial fibrillation. European Heart Journal Supplements. 2018;20(Suppl A):A10–4. DOI: 10.1093/eurheartj/sux036
87. Fellahi J-L, Heringlake M, Knotzer J, Fornier W, Cazenave L, Guarracino F. Landiolol for managing atrial fibrillation in post-cardiac surgery. European Heart Journal Supplements. 2018;20(Suppl A):A4–9. DOI: 10.1093/eurheartj/sux038
88. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(3):e153–93. DOI: 10.1016/j.jtcvs.2014.06.036
89. Muehlschlegel JD, Burrage PS, Ngai JY, Prutkin JM, Huang C-C, Xu X et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. Anesthesia & Analgesia. 2019;128(1):33–42. DOI: 10.1213/ANE.0000000000003865
90. Mehaffey JH, Hawkins RB, Byler M, Smith J, Kern JA, Kron I et al. Amiodarone Protocol Provides Cost-Effective Reduction in Postoperative Atrial Fibrillation. The Annals of Thoracic Surgery. 2018;105(6):1697–702. DOI: 10.1016/j.athoracsur.2017.12.029
91. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial. JAMA. 2005;294(24):3093. DOI: 10.1001/jama.294.24.3093
92. Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta-analysis. Pacing and Clinical Electrophysiology. 2013;36(8):1017–23. DOI: 10.1111/pace.12140
93. Onk OA, Erkut B. Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery? Medicine. 2015;94(41):e1576. DOI: 10.1097/MD.0000000000001576
94. Alqahtani AwadAR. Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010;11(2):57–63. DOI: 10.4103/1995-705X.73212
95. Zheng H, Xue S, Hu Z-L, Shan J-G, Yang W-G. The Use of Statins to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Meta-analysis of 12 Studies. Journal of Cardiovascular Pharmacology. 2014;64(3):285–92. DOI: 10.1097/FJC.0000000000000102
96. Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. Journal of Cardiovascular Pharmacology and Therapeutics. 2016;21(2):167–76. DOI: 10.1177/1074248415602557
97. Bokeriya O.L., Akhobekov A.A., Shvarts V.A., Kudzoeva Z.F. Efficacy of Statin Therapy in the Prevention of Atrial Fibrillation in Early Postoperative Period after Coronary Artery Bypass Grafting. Annals of the Russian Academy of Medical Sciences. 2015;70(3):273–8. DOI: 10.15690/vramn.v70i3.1322
98. Chopra V, Wesorick DH, Sussman JB, Greene T, Rogers M, Froehlich JB et al. Effect of Perioperative Statins on Death, Myocardial Infarction, Atrial Fibrillation, and Length of Stay: A Systematic Review and Meta-analysis. Archives of Surgery. 2012;147(2):181–9. DOI: 10.1001/archsurg.2011.897
99. Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study. Circulation. 2006;114(14):1455–61. DOI: 10.1161/CIRCULATIONAHA.106.621763
100. Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database of Systematic Reviews. 2013;7:CD009971. DOI: 10.1002/14651858.CD009971.pub2
101. Putzu A, Capelli B, Belletti A, Cassina T, Ferrari E, Gallo M et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Critical Care. 2016;20(1):395. DOI: 10.1186/s13054-016-1560-6
102. Ishii Y, Schuessler RB, Gaynor SL, Hames K, Damiano RJ. Postoperative atrial fibrillation: The role of the inflammatory response. The Journal of Thoracic and Cardiovascular Surgery. 2017;153(6):1357–65. DOI: 10.1016/j.jtcvs.2016.12.051
103. Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman CI. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007;4(4):461–8. DOI: 10.1016/j.hrthm.2006.11.026
104. Dieleman JM. Intraoperative High-Dose Dexamethasone for Cardiac Surgery: A Randomized Controlled Trial. JAMA. 2012;308(17):1761–7. DOI: 10.1001/jama.2012.14144
105. Dvirnik N, Belley-Cote EP, Hanif H, Devereaux PJ, Lamy A, Dieleman JM et al. Steroids in cardiac surgery: a systematic review and meta-analysis. British Journal of Anaesthesia. 2018;120(4):657–67. DOI: 10.1016/j.bja.2017.10.025
106. Boeva O.I., Kolesnikov V.N., Ivanenko A.S., Krasnov A.Yu., Bulgakova N.E., Shcheglova E.V. New opportunities for the prevention of postoperative atrial fibrillation. Modern Problems of Science and Education. 2015;5:134. DOI: 10.17513/spno.128-21966
107. Panov A.V., Tatarskiy B.A., Gordeev M.L., Nilk R.Ya. Omega-3 polyunsaturated fatty acids In atrial fibrillation prevention after surgical myocardial revascularization. Rational Pharmacotherapy in Cardiology. 2008;4(3):26–32.
108. Zhang B, Zhen Y, Tao A, Bao Z, Zhang G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated meta-analysis of randomized controlled trials. Journal of Cardiology. 2014;63(1):53–9. DOI: 10.1016/j.jjcc.2013.06.014
109. Wang H, Chen J, Zhao L. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review. Journal of Interventional Cardiac Electrophysiology. 2018;51(2):105–15. DOI: 10.1007/s10840-018-0315-5
110. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines on management of atrial fibrillation developedin collaboration with EACTS. Russian Journal of Cardiology. 2017;22(7):7–86. DOI: 10.15829/1560-4071-2017-7-7-86
111. Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M et al. Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care. 2015;38(9):1665–72. DOI: 10.2337/dc15-0303
112. Borodashkina S.Yu., Podkamenny V.A., Protasov K.V. Cardiovascular complications and the state of carbohydrate metabolism during coronary artery bypass grafting on a “working heart” depending on the regimen of hypoglycemic therapy in patients with coronary heart disease and type 2 diabetes. Russian Journal of Cardiology. 2016;21(2):19–24. DOI: 10.15829/1560- 4071-2016-2-19-24
Review
For citations:
Petrakova E.S., Savina N.M., Molochkov A.V. Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment. Kardiologiia. 2020;60(9):134-148. (In Russ.) https://doi.org/10.18087/cardio.2020.9.n1074
Views:
2577
Email this article 
Post a Comment 
